Daré Bioscience holds special stockholder meeting
DARE•Daré Bioscience shareholders approved the potential future issuance of common stock upon exercise of outstanding warrants at a November 10, 2026 special meeting.
1. Shareholder vote
Shareholders also authorized adjournment of the meeting to solicit additional proxies supporting the issuance, but sufficient votes made an adjournment unnecessary.




